A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma.
Hempel L, Lapa C, Dierks A, Gaumann A, Scheiber J, Veloso de Oliveira J, Philipp P, Oyarzun Laura C, Wesarg S, Robert S, Hempel D.
Hempel L, et al. Among authors: wesarg s.
Ther Adv Med Oncol. 2022 Sep 26;14:17588359221125096. doi: 10.1177/17588359221125096. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 36188486
Free PMC article.